Evidence map›Paper›PMID 40920188›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2025

Latin American patients' perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America.

P Clark, M Caló, S T Bostico, A Orcesi de Pedro, G Altamar, M L Morato Hernández, J E Levin Ford, M P Cornejo Ortega, C Firpo, M V Barrachina and 1 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

P ClarkClinical Epidemiology Unit. Universidad Autónoma de Mexico (UNAM) Faculty of Medicine and Hospital Infantil Federico Gómez, CDMX, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-7981-5357
M CalóOsteoporosis Foundation IOF Regional Office, CDMX, Mexico City, Mexico. monica.calo@osteoporosis.foundation.ORCID http://orcid.org/0000-0002-1868-5576
S T BosticoSanatorio Las Lomas - CEM (Centro de Endocrinología, Nutrición y Diabetes), San Isidro, BA, Argentina.
A Orcesi de PedroFederação Brasileira de Associações de Ginecologia e Obstetrícia (FEBRASGO), Universidade Estadual de Campina, São Paulo, Brazil.
G AltamarAsociación Colombiana de Osteoporosis y Metabolismo Mineral (ACOMM), Universidad del Valle, Bogotá, Colombia.
M L Morato HernándezAmerican British Cowdray Enocrinology; Asociación Mexicana de Metabolismo Óseo y Mineral (AMMOM), CDMX, Mexico City, Mexico.
J E Levin FordFundación de Osteoporosis y Enfermedades Metabólicas Óseas (FOSEMO), Ciudad de Panamá, Panamá.
M P Cornejo OrtegaJefe del Servicio de Inmunoreumatología del Hospital Nacional Arzobispo Loayza, Sociedad Peruana de Reumatología, Lima, Perú.ORCID http://orcid.org/0000-0002-5431-4254
C FirpoSanatorio Las Lomas - CEM (Centro de Endocrinología, Nutrición y Diabetes), San Isidro, BA, Argentina.
M V BarrachinaOsteoporosis Foundation IOF Regional Office, CDMX, Mexico City, Mexico.
J Y ReginsterInternational Osteoporosis Foundation, Nyon, Switzerland.ORCID http://orcid.org/0000-0001-6290-752X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study explored osteoporosis patients' views on the disease in six LATAM countries. All were diagnosed for over 3 years, 65% avoiding fragility fractures. Sixteen used osteoporosis drugs, trusting physicians most. Though osteoporosis has moderately impacted their quality of life, all fear a future of falls and loss of independence. PURPOSE: The aim of this study was to understand osteoporosis patients' perceptions, behaviors, and expectations in relation to diagnosis and treatment.

methodsA convenience sample of 20 patients from six different LATAM countries constituted a focal group. All participants were diagnosed with osteoporosis and in treatment at various stages of the disease. The study was conducted in two phases: the first one involved a cross-sectional survey using an instrument developed by the IOF which was tailored to local needs, and the second consisted of a focus group in a hybrid format.

resultsThe twenty participants were diagnosed with osteoporosis for less than 3 years, most of them received treatment and did not fracture. Treating physicians was the most trusted source of information, while influencers and media were seen as unreliable. Osteoporosis had a moderate impact on patients' quality of life, with only a few requiring help with daily chores. The qualitative phase revealed that patients who received care at private institutions had better access to information about the disease and treatment options. Despite the minimal impact on their current quality of life, patients showed concern about future risks like falls and loss of independence.

conclusionBeing diagnosed with osteoporosis has a significant impact on people's daily life, independently whether a fracture occurred, received treatment, embraced a healthy bone lifestyle or trust own treating physician. Fear of fractures and their consequences underly patients' perceptions which is seen as not considered enough by physicians, health authorities, drug companies, NGOs and media.

Indexed as

Attitude to HealthHealth Knowledge, Attitudes, PracticeOsteoporosisAdultAgedAged, 80 and overBone Density Conservation AgentsCross-Sectional StudiesFemaleFocus GroupsHumansLatin AmericaMaleMiddle AgedOsteoporotic FracturesPhysician-Patient RelationsBone Density Conservation AgentsBehaviorsOsteoporosis knowledgePatient centricityPatient journeyTreatment perception

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.